175 related articles for article (PubMed ID: 33117486)
1. Mucocutaneous leishmaniasis: case report and literature review of a rare endonasal infection.
Suqati AA; Pudszuhn A; Hofmann VM
Pan Afr Med J; 2020; 36():292. PubMed ID: 33117486
[TBL] [Abstract][Full Text] [Related]
2. Mucosal Leishmania infantum infection.
Richter J; Hanus I; Häussinger D; Löscher T; Harms G
Parasitol Res; 2011 Sep; 109(3):959-62. PubMed ID: 21499751
[TBL] [Abstract][Full Text] [Related]
3. Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa.
Di Lella F; Vincenti V; Zennaro D; Afeltra A; Baldi A; Giordano D; Pasanisi E; Bacciu A; Bacciu S; Di Lella G
Int J Oral Maxillofac Surg; 2006 Sep; 35(9):870-2. PubMed ID: 16574379
[No Abstract] [Full Text] [Related]
4. New World leishmaniasis from Spain.
Tomson N; Symonds RP; Moir AA; Kendall CH; Wiselka MJ
Postgrad Med J; 2002 Dec; 78(926):757-8. PubMed ID: 12509697
[TBL] [Abstract][Full Text] [Related]
5. Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports.
Crovetto-Martínez R; Aguirre-Urizar JM; Orte-Aldea C; Araluce-Iturbe I; Whyte-Orozco J; Crovetto-De la Torre MA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):e20-6. PubMed ID: 25442251
[TBL] [Abstract][Full Text] [Related]
6. Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.
Basile G; Cristofaro G; Locatello LG; Vellere I; Piccica M; Bresci S; Maggiore G; Gallo O; Novelli A; Di Muccio T; Gramiccia M; Gradoni L; Gaiera G; Bartoloni A; Zammarchi L
Int J Infect Dis; 2020 Aug; 97():204-207. PubMed ID: 32505874
[TBL] [Abstract][Full Text] [Related]
7. [Primary Leishmania infantum MON-80 endonasal leishmaniasis in Tunisia].
Benmously-Mlika R; Fenniche S; Kerkeni N; Aoun K; Khedim A; Mokhtar I
Ann Dermatol Venereol; 2008 May; 135(5):389-92. PubMed ID: 18457726
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous leishmaniasis with secondary mucosal disease in a traveller due to Leishmania (Viannia) braziliensis.
Crone CG; Helleberg M
J Travel Med; 2020 Feb; 27(1):. PubMed ID: 31776570
[No Abstract] [Full Text] [Related]
9. Mucocutaneous leishmaniasis treated with liposomal amphotericin B.
Lambertucci JR; Silva LC
Rev Soc Bras Med Trop; 2008; 41(1):87-8. PubMed ID: 18368279
[No Abstract] [Full Text] [Related]
10. [Mucocutaneous leishmaniasis in otorhinolaryngology].
Patuano E; Carrat X; Drouet Y; Barnabé D; Vincey P; Berthelot B
Ann Otolaryngol Chir Cervicofac; 1993; 110(7):415-9. PubMed ID: 8085723
[TBL] [Abstract][Full Text] [Related]
11. Successful response to liposomal amphotericin B in mucosal leishmaniasis in glans resistant to intralesional pentavalent.
Aguayo-Carreras P; Cuenca-Barrales C; Perez-López I; Ruiz-Villaverde R; Tercedor-Sanchez J
Int J Dermatol; 2019 Jul; 58(7):e137-e138. PubMed ID: 30883705
[No Abstract] [Full Text] [Related]
12. Localized mucosal leishmaniasis caused by Leishmania infantum mimicking cancer in the rhinolaryngeal region.
Cobo F; Rodríguez-Granger J; Gómez-Camarasa C; Sampedro A; Aliaga-Martínez L; Navarro JM; Fernández JG
Int J Infect Dis; 2016 Sep; 50():54-6. PubMed ID: 27515498
[TBL] [Abstract][Full Text] [Related]
13. Mucocutaneous leishmaniasis caused by Leishmania infantum var Lombardi in an immunocompetent patient, Spain.
Freites-Martinez A; Córdoba S; Bermejo A; Borbujo J
Enferm Infecc Microbiol Clin; 2015; 33(7):499-500. PubMed ID: 25559703
[No Abstract] [Full Text] [Related]
14. Mucocutaneous leishmaniasis of the nose: a case report.
Menten K; Soentjens P; Caenepeel P; Lemkens P
B-ENT; 2015; 11(1):77-80. PubMed ID: 26513953
[TBL] [Abstract][Full Text] [Related]
15. Treatment of mucosal leishmaniasis (L. infantum) with miltefosine in a patient with Good syndrome.
Stoeckle M; Holbro A; Arnold A; Neumayr A; Weisser M; Blum J
Acta Trop; 2013 Oct; 128(1):168-70. PubMed ID: 23871798
[TBL] [Abstract][Full Text] [Related]
16. [Nasal leishmaniasis in an HIV-positive patient].
Grasa JM; Lorente J; Crego F; Naches S; Subirana FX; Calderón JR; Pollán C; Encarnación LF; Quesada P
Acta Otorrinolaringol Esp; 2000 Mar; 51(2):169-73. PubMed ID: 10804122
[TBL] [Abstract][Full Text] [Related]
17. Leishmaniasis of the nose caused by different species of Leishmania in the Sudan. Distinguishing features of the different clinical forms.
el-Hassan AM; Yagi HI; Zijlstra EE; el-Kadarow AI
Trop Geogr Med; 1994; 46(1):33-6. PubMed ID: 8165735
[TBL] [Abstract][Full Text] [Related]
18. First molecular-based detection of mucocutaneous leishmaniasis caused by Leishmania major in Iran.
Alborzi A; Pouladfar GR; Ghadimi Moghadam A; Attar A; Drakhshan N; Khosravi Maharlooei M; Kalantari M
J Infect Dev Ctries; 2013 May; 7(5):413-6. PubMed ID: 23669431
[TBL] [Abstract][Full Text] [Related]
19.
Grech P; Vella SM; Piscopo T
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33139372
[TBL] [Abstract][Full Text] [Related]
20. The histological spectrum of non-granulomatous localized mucosal leishmaniasis caused by Leishmania infantum.
Cobo F; Aliaga L; Talavera P; Concha A
Ann Trop Med Parasitol; 2007 Dec; 101(8):689-94. PubMed ID: 18028730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
